Austar Lifesciences Limited

SEHK:6118 Rapporto sulle azioni

Cap. di mercato: HK$328.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Austar Lifesciences Dividendo

Dividendo criteri di controllo 0/6

Austar Lifesciences al momento non paga dividendi.

Informazioni chiave

0%

Rendimento del dividendo

0%

Rapporto di remunerazione

Rendimento medio del settore1.3%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azioneHK$0.0494
Utile per azione-HK$0.038
Previsione del rendimento del dividendo a 3 annin/a

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues

Aug 28
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues

We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package

May 24
We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package

Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive

Apr 18
Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive

Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?

Mar 28
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?

Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump

Feb 12
Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump

Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues

Dec 22
Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues

We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt

Sep 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt

Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden

Mar 31
Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden

Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Sep 19
Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Austar Lifesciences (HKG:6118) A Risky Investment?

Apr 06
Is Austar Lifesciences (HKG:6118) A Risky Investment?

Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet

Oct 24
Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting

Sep 27
With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting

If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late

Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly

Mar 31
Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?

Mar 01
Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?

Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Feb 01
Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 11
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?

Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly

Dec 21
Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly

Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?

Dec 07
Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?

Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like

Nov 23
Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di 6118 siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di 6118 siano aumentati.


Rendimento dei dividendi rispetto al mercato

Austar Lifesciences Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di 6118 rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (6118)0%
Fondo del 25% del mercato (HK)3.5%
Top 25% del mercato (HK)8.4%
Media del settore (Life Sciences)1.3%
Previsione dell'analista in 3 anni (6118)n/a

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di 6118 rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di 6118 rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.


Distribuzione degli utili agli azionisti

Copertura degli utili: 6118 non sta pagando un dividendo degno di nota per il mercato Hong Kong.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché 6118 non ha segnalato alcun pagamento.


Scoprire le società che pagano dividendi forti